1. Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifeneTina Trdan Lušin, Bruno Stieger, Janja Marc, Aleš Mrhar, Jurij Trontelj, Andrej Zavratnik, Barbara Ostanek, 2012, original scientific article Keywords: raloksifen, osteoporoza, SLCO1B1, SLCO1B3 Full text (outside link) |
|
|
4. In vitro bioactivation of bazedoxifene and 2-(4-hydroxyphenyl)-3-methyl-1Hindol- 5-ol in human liver microsomesTina Trdan Lušin, Tihomir Tomašič, Jurij Trontelj, Aleš Mrhar, Lucija Peterlin-Mašič, 2012, original scientific article Keywords: bazedoksifen, raloksifen, LC-MS/MS, citokrom P450, osteporoza Full text (outside link) |
5. Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatmentTina Trdan Lušin, Aleš Mrhar, Bruno Stieger, Gerd A. Kullak-Ublick, Janja Marc, Barbara Ostanek, Andrej Zavratnik, Albin Kristl, Katja Berginc, Katja Delić, Jurij Trontelj, 2012, original scientific article Keywords: raloksifen, osteoporoza, zdravljenje, farmakokinetika, farmakodinamika Full text (outside link) |
|
7. Vpliv polimorfizmov v genih za prenašalne proteine OATP1B1, OATP1B3, P-GP in MRP2Katja Delić, 2012, master's thesis Keywords: osteoporoza, raloksifen, polimorfizmi v genih, prenašalni proteini, zdravljenje osteoporoze, farmakokinetika raloksifena, farmakodinamski parametri Full text (outside link) |
|
|
|